Neurocrine Biosciences (0K6R.L)

Financial Performance

Neurocrine Biosciences has been showing a strong financial performance with its revenue of $622.1M in the last quarter, which is an increase by 20.7% YoY and 5.4% QoQ. The gross profit also saw a significant growth of 21.2% YoY and 6.9% QoQ reaching $614.1M, indicating efficient operations and cost management strategies from the company's end.

The operating income profit was $183.8M, up by impressive margins both YoY (22.3%) and QoQ (24.3%). The EBITDA ratio at the end of the last quarter was solid at 0.31, suggesting that the company has healthy profitability.

Stock Price

The stock price currently stands at $138.3, having risen by a substantial margin of 7.6% over the past month and by a modest margin of 5.8% over the past year.

In terms of technical indicators, Neurocrine Biosciences' RSI value is currently at a balanced level of around 61.42 suggesting neither overbought nor oversold conditions for its stock while it's trading significantly above its long-term moving average ($114).

Alternative Data Signals

The company's web traffic has surged recently with an estimated monthly visitor count growing by around +7%. This indicates increasing interest or awareness about Neurocrine Biosciences among potential investors or customers.

A surge in job postings (+46%) suggests expansion plans or increased activity within the firm whereas employee sentiment remains overwhelmingly positive with an estimated business outlook score standing unchanged at an impressive 94%.

Lastly, the company's social media presence has also been growing with a significant increase in followers on Twitter (+12.9%) and Facebook (+50.5%), adding to its visibility.

Conclusion

In conclusion, Neurocrine Biosciences exhibits robust financial performance, positive stock price momentum, and strong alternative data signals which point towards a bullish outlook for the stock.

Note: This AI Stock Analysis is based on data as of January 11. Our members can refresh and get access to an up-to-date AI stock analysis.

Sign up

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $143.5, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.